Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q1 2026 · 10-Q
Revenue$7.68M$7.68M−3.6% vs Q1 2025 Net Income$47.11K$47.11K−83.3% vs Q1 2025 EPS Diluted$0.01$0.01−66.7% vs Q1 2025 Operating Income$765,134−27.5% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
Free Cash Flowderived$584,762−34.4% Margins · derivedOperating margin10.0%−3.3 pt vs Q1 2025
Net margin0.6%−2.9 pt vs Q1 2025
ended Feb 28, 2026 · filed Apr 14, 2026 · 45 d after period end